NEPPG
MRNA icon

New England Professional Planning Group’s Moderna MRNA Stock Holding History

New England Professional Planning Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-641
Closed -$247K – 52
2021
Q2 		$247K Buy
+641
New +$115K 0.15% 36

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

New England Professional Planning Group's MRNA Position: Q3 2021 in Review

New England Professional Planning Group sold out of Moderna (MRNA) in Q3 2021, closing a stake of 641 shares — an estimated $247K sold.

New England Professional Planning Group first reported a position in MRNA in Q2 2021 and held it in 1 quarter. The position peaked at $247K in Q2 2021. 1,141 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • New England Professional Planning Group reported no remaining Moderna position as of Q3 2021 after selling out during the quarter.
  • New England Professional Planning Group sold 641 Moderna shares in Q3 2021, an estimated $247K.
  • New England Professional Planning Group first reported a position in Moderna in Q2 2021 and held it in 1 quarter.
  • New England Professional Planning Group's Moderna position peaked at $247K in Q2 2021.
  • 1,141 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on New England Professional Planning Group's 13F filing for Q3 2021, filed 5 Nov 2021.